Unlock the Secret to Crafting Compelling Core Values With This Step-by-Step Guide
Core values are vital to a company’s identity, going beyond generic terms to embody unique, actionable principles. Here’s how to craft the best ones.
The Download: AI-enhanced cybercrime, and secure AI assistants
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. AI is already making online crimes easier. It could get much worse. Just as software engineers are using artificial intelligence to help write code and check for bugs, hackers are using these tools…
In the fight against Methane, a key GHG, Valley investors have hit upon an unusual target: Cow burps
What do iconic Valley investors Zachary Bogue and Chris Sacca have in common? They are both trying to stop cows from burping methane. No, really. And a Sacca investment just raised $20 million to do just that. What gives? With the conclusion of COP28, the global talks on the climate crisis, Methane is going up […]
© 2023 TechCrunch. All rights reserved. For personal use only.
Vertex developed a CRISPR cure. It’s already on the hunt for something better.
The company that just got approval to sell the first gene-editing treatment in history, for sickle-cell disease, is already looking for an ordinary drug that could take its place. Vertex Pharmaceuticals has a 50-person team working “to make a pill that doesn’t do gene editing at all,” says David Altshuler, head of research at the…
Decoding Buy or Hold for These 3 Software Stocks
The software industry is experiencing a surge in demand driven by rising digitization and a significant transition toward cloud-based solutions. Given this backdrop, let’s decode whether software stocks Palo Alto…
Needle-free covid vaccines are (still) in the works
This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here. Covid shots do an admirable job of boosting our immune response enough to protect against serious illness, but they don’t boost immunity in the one spot…
Will this year’s top performing stock ETFs stay hot in ’24?
Even if there is a clear market rotation, these top performing ETFs will have an opportunity to secure gains and move on to be potential trophy winners in 2024.
Shift Into High Gear with These 3 Auto Stocks Primed for December Rally
Rising consumer demand for new vehicles and stabilizing inventory levels, alongside an intensified global shift toward electric vehicles (EVs), set the stage for robust growth within the automotive industry. Therefore,…
Ex-Facebook Exec Admits to Stealing $4 Million from the Company to Fund Her Lavish Lifestyle
Barbara Furlow-Smiles used Meta money for personal expenses, including a $18,000 preschool tuition.
Boost Your Productivity with Coworking Spaces to Prevent Burnout
Protection against burnout is important and helps not to lose valuable employees, but at the same time increase their productivity.
What is happening with all these new venture funds?
Against a backdrop of layoffs and continuing economic uncertainty, the announcements — particularly in such quick succession — point to a few underlying truths about the market right now.
© 2023 TechCrunch. All rights reserved. For personal use only.